Search research articles
Contact Us
Filters
Showing results (151-160 of 174) with videos related to
Page
of 18
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 23, 2025
Impact of Surgical Resection on Hepatocellular Carcinoma Following Systemic Drug Therapy: A Multicenter Retrospective Observational Study
Takamichi Ishii, Junichi Shindoh, Ikuo Nakamura, et al.
Liver Cancer
|
July 11, 2020
Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall Prognosis
Yusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, et al.
Liver Cancer
|
June 19, 2024
A Multicenter Phase 2 Trial Evaluating the Efficacy and Safety of Preoperative Lenvatinib Therapy for Patients with Advanced Hepatocellular Carcinoma (LENS-HCC Trial)
Akihiko Ichida, Junichi Arita, Etsuro Hatano, et al.
Cancer
|
July 4, 2013
Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma
Ahmed O Kaseb, Junichi Shindoh, Yehuda Z Patt, et al.
Oncology
|
September 14, 2022
The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment: An Imaging-Based Analysis
Nozomu Muraishi, Yusuke Kawamura, Norio Akuta, et al.
Cancers
|
August 12, 2023
Efficacy of the Combination of Systemic Sequential Therapy and Locoregional Therapy in the Long-Term Survival of Patients with BCLC Stage C Hepatocellular Carcinoma
Yusuke Kawamura, Norio Akuta, Junichi Shindoh, et al.
Oncology
|
March 1, 2022
Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Early Progressive Disease following Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma
Yusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, et al.
Annals of Surgery
|
May 24, 2014
Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study
Junichi Shindoh, Xabier de Aretxabala, Thomas A Aloia, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
September 30, 2018
Conceptual framework of middle hepatic vein anatomy as a roadmap for safe right hepatectomy
Satoshi Ogiso, Masayuki Okuno, Junichi Shindoh, et al.
Oncology
|
June 17, 2021
Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Overall Prognosis Following Lenvatinib Treatment
Yusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 174) with videos related to
Sort By:
Page
of 18
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 23, 2025
Impact of Surgical Resection on Hepatocellular Carcinoma Following Systemic Drug Therapy: A Multicenter Retrospective Observational Study
Takamichi Ishii, Junichi Shindoh, Ikuo Nakamura, et al.
Liver Cancer
|
July 11, 2020
Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall Prognosis
Yusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, et al.
Liver Cancer
|
June 19, 2024
A Multicenter Phase 2 Trial Evaluating the Efficacy and Safety of Preoperative Lenvatinib Therapy for Patients with Advanced Hepatocellular Carcinoma (LENS-HCC Trial)
Akihiko Ichida, Junichi Arita, Etsuro Hatano, et al.
Cancer
|
July 4, 2013
Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma
Ahmed O Kaseb, Junichi Shindoh, Yehuda Z Patt, et al.
Oncology
|
September 14, 2022
The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment: An Imaging-Based Analysis
Nozomu Muraishi, Yusuke Kawamura, Norio Akuta, et al.
Cancers
|
August 12, 2023
Efficacy of the Combination of Systemic Sequential Therapy and Locoregional Therapy in the Long-Term Survival of Patients with BCLC Stage C Hepatocellular Carcinoma
Yusuke Kawamura, Norio Akuta, Junichi Shindoh, et al.
Oncology
|
March 1, 2022
Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Early Progressive Disease following Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma
Yusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, et al.
Annals of Surgery
|
May 24, 2014
Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study
Junichi Shindoh, Xabier de Aretxabala, Thomas A Aloia, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
September 30, 2018
Conceptual framework of middle hepatic vein anatomy as a roadmap for safe right hepatectomy
Satoshi Ogiso, Masayuki Okuno, Junichi Shindoh, et al.
Oncology
|
June 17, 2021
Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Overall Prognosis Following Lenvatinib Treatment
Yusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, et al.
Page
of 18